Sell signal keeps losing steam
Recursion rises 1.4%, but the Sell signal keeps losing steam
Sell signal keeps losing steam
Our view last week
After last week's plunge, Recursion Pharmaceuticals catches its breath: the stock closes +0.5% and forms a double bottom in the 2.9 area, with a 6% rebound off the lows. In this week's Recursion technical analysis, signal strength drops from 98 to 34 out of 100, a decline losing steam; but sellers still hold the upper hand, with only 23.5% of volume on the buy side and money flow still negative.
This week's summary
The stock rises 1.4% for the week, but the price action stays murky: mixed rejection candles and a distribution phase still underway show the Sell signal, though losing steam, hasn't given up yet. In this week's Recursion technical analysis, strength drops to 2 out of 100, after already sliding from 98 to 34 the week before: the decline has burned through nearly all its push. Earnings are close, on August 11, adding weight to caution; the band stays trading-not-recommended.
Sell signal in observation
·3rd week from start
·US stocks
·T2
·📅 Earnings · Aug 11
★ See Gold version →
IQS Phase
69
in tension
Signal Strength
2
decline losing steam
Sizing
MINIMUM
Ranking
#129 / 138
US stocks sell signals
Trade P&L %
-1.87%
from signal to date, no stop loss
Rank position
ranks 129th among the 138 sell signals for US stocks in our ranking, with a signal strength of 2 out of 100.
Sector context
SectorHealth Care
Benchmark ETFXLV
Sector regimein positive regime
Performanceweekly -0.01% · monthly +1.89%
RXRX belongs to the health care sector (reference ETF XLV). The sector is classified in positive regime according to our weekly reading.
restricted Platinum content